GGHC
KERX

Gilder Gagnon Howe & Co’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-18,631
Closed -$317K – 329
2014
Q1 		$317K Sell
18,631
-122
-0.7% -$2.08K ﹤0.01% 238
2013
Q4 		$243K Sell
18,753
-2,520
-12% -$32.7K ﹤0.01% 236
2013
Q3 		$215K Sell
21,273
-1,177,148
-98% -$11.9M ﹤0.01% 237
2013
Q2 		$8.95M Buy
+1,198,421
New +$8.95M 0.17% 107